ATG-112

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameATG-112
Drug Alias NameATG-112ATG112
ClassificationBiologics > T cell engagersBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsAlkaline Phosphatase, Placental Like 2 modulators
TargetsT cell surface glycoprotein CD3Alkaline Phosphatase, Placental Like 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corp Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A